Prana Biotechnology (PRAN) gains 6% premarket after the firm announces that it secured a key...

|About: Prana Biotechnology Ltd (PRAN)|By:, SA News Editor

Prana Biotechnology (PRAN) gains 6% premarket after the firm announces that it secured a key patent for its Parkinson's disease treatment from the USPTO.  CEO Geoffrey Kempler says the granted rights will further boost Prana's commercialization plans after a grant from the Michael J. Fox Foundation helped allow the firm to undertake development studies.